Journal
PROTEIN & CELL
Volume 8, Issue 3, Pages 191-201Publisher
SPRINGEROPEN
DOI: 10.1007/s13238-016-0345-7
Keywords
IL-25; breast cancer; metastasis; MMTV-PyMT
Categories
Funding
- Tsinghua University-Peking University Center for Life Sciences
Ask authors/readers for more resources
Metastasis is the leading cause of death in breast cancer patients. However, the mechanisms underlying metastasis are not well understood and there is no effective treatment in the clinic. Here, we demonstrate that in MMTV-PyMT, a highly malignant spontaneous breast tumor model, IL-25 (also called IL-17E) was expressed by tumor-infiltrating CD4(+) T cells and macrophages. An IL-25 neutralization antibody, while not affecting primary tumor growth, substantially reduced lung metastasis. Inhibition of IL-25 resulted in decreased type 2 T cells and macrophages in the primary tumor microenvironments, both reported to enhance breast tumor invasion and subsequent metastasis to the lung. Taken together, our data suggest IL-25 blockade as a novel treatment for metastatic breast tumor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available